about
Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor SystemThe role of biomarkers and imaging in Parkinson's disease.MALDI imaging of post-mortem human spinal cord in amyotrophic lateral sclerosis.Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeysFunctional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAPThe use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.Closing the gap between brain banks and proteomics to advance the study of neurodegenerative diseases.Deep brain stimulation-associated brain tissue imprints: a new in vivo approach to biological research in human Parkinson's diseasePesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.Mitochondrial proteomic profiling reveals increased carbonic anhydrase II in aging and neurodegeneration.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.Proteomics uncovering possible key players in F508del-CFTR processing and trafficking.Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy.Proteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.Energy matters: mitochondrial proteomics for biomedicine.Mammalian plasma membrane proteins as potential biomarkers and drug targets.Biofunctionalisation of polymeric scaffolds for neural tissue engineering.Biomarkers for trials of neuroprotection in Parkinson's disease.Long-term effects of ionising radiation on the brain: cause for concern?Selenium and selenoprotein function in brain disorders.Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis.Integrative biomarker discovery in neurodegenerative diseases.Targeted Annotation of S-Sulfonylated Peptides by Selective Infrared Multiphoton Dissociation Mass Spectrometry.Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment.Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.Proteomic studies associated with Parkinson's disease.Rutin from Dendropanax morbifera Leveille protects human dopaminergic cells against rotenone induced cell injury through inhibiting JNK and p38 MAPK signaling.Glycosylation of the sodium channel β4 subunit is developmentally regulated and involves in neuritic degeneration.Direct interaction of α-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease.Detoxified extract of Rhus verniciflua stokes inhibits rotenone-induced apoptosis in human dopaminergic cells, SH-SY5Y.Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.Obesity and neurological disorders: Dietary perspective of a global menace.Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.Role of Ionizing Radiation in Neurodegenerative Diseases.
P2860
Q26999386-08752705-DCF8-4BCE-8D50-54254CB6BCBEQ31041660-22A47D99-472C-4984-BCBE-2B25CDAB992EQ31096152-D371D675-C503-40AD-809A-B738939D9911Q34990005-7B1570B0-2898-402B-95B0-E958FF01B7F1Q34995536-27784503-96C9-4589-995F-BBEC01BAE643Q35767234-42EA2708-91A4-4380-8ADD-764757F93473Q36052708-7F6C3314-225D-4D7E-A608-7E472A67FB4EQ36284919-82AF9E70-5598-420E-BE33-D28E80CCA505Q36513900-B075D6BD-D1CE-45A3-BA62-B8B139605ED6Q37320854-B7E236C2-6894-4BB0-87BD-5F17328D0A7FQ37423536-CFAD3951-B444-4503-96BF-9274B024C2C4Q37685124-B96947C1-F81E-41F7-9D50-8243B9C220F8Q37775034-B1202DEB-071B-4FE0-98FA-1C92CDECC6D3Q37775037-948F58DA-577F-456A-AB4A-8912146A581AQ37818319-2C891AF2-CB05-44C0-A1E0-F64C7727F317Q37829412-3C6F7F2E-EDCC-4E11-904C-1A37FA6F13D0Q37894617-FEA09460-5DBF-44DB-9EDA-BFD39477ECB0Q38001616-80A4EB28-214A-4A10-AC5E-C3EDF3ED542BQ38038544-CD6552F6-F60A-49C9-A893-A6ED5331537FQ38055706-095E89DC-9D23-432A-8C48-D111E1B4CC42Q38199451-25D56BC9-C546-4E22-9EFE-F854A498D146Q38437443-754CD6E5-234E-4925-BED3-9C4A918204BCQ38542025-1DD7676A-4A68-4531-B9D2-CE41359335D0Q38679121-D037DC0C-E7E9-4256-8619-9891D5ECF422Q38725685-20251539-6E36-42CF-9AEB-3DFE2D9F7632Q38726592-8072F14B-066C-40E8-9960-6AC44159C8E4Q38761409-5BD0FEAC-69D4-46D7-832A-74C1D255D5C9Q39022814-191F31E9-7BF3-42DD-8A96-C5EA2FFA3D09Q39354416-9EC804BD-42B0-424D-A284-EA964AA6BB28Q39562119-15A2A1CE-F1DE-4D3E-B2C8-8D6DD2E7B8B5Q39634218-D5148362-A946-4831-A9FB-F5853472EE4CQ47395290-F3CC7557-BCE8-4A4B-A8F4-49B378B84C73Q48564253-F644CBFE-1C77-46B2-A120-94C37A1026DBQ53455700-35CCB555-B858-4F56-B8D7-6B4402BEB435Q55112653-F3AF0CAA-5050-48B6-A707-3E616A76FA60
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomics in human Parkinson's disease research.
@en
Proteomics in human Parkinson's disease research.
@nl
type
label
Proteomics in human Parkinson's disease research.
@en
Proteomics in human Parkinson's disease research.
@nl
prefLabel
Proteomics in human Parkinson's disease research.
@en
Proteomics in human Parkinson's disease research.
@nl
P2093
P1476
Proteomics in human Parkinson's disease research.
@en
P2093
Denis F Hochstrasser
Enikö Kövari
Pierre R Burkhard
Virginie Licker
P356
10.1016/J.JPROT.2009.07.007
P577
2009-07-24T00:00:00Z